We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Map Diagnostics Developing Mass Spec Test for Down Syndrome

News   May 15, 2015

 
Map Diagnostics Developing Mass Spec Test for Down Syndrome
 
 
 

RELATED ARTICLES

Stage Set for Uncovering Multiple Autoimmune Drug Targets

News

The identification of molecular signatures that reflect the pathology of lupus and arthritis provide new insights into tissue damage, and set the stage for uncovering potential drug target candidates.

READ MORE

Starving Cancer: Drug Drains Melanoma Cells of Their Energy

News

Researchers have found that two structurally similar compounds – deguelin and rotenone, naturally occurring pesticides produced by many plant species – interfered with melanoma cancer cells’ metabolism. Further testing with deguelin showed that it inhibited oxygen consumption in the cells’ mitochondria, effectively starving the cells of energy.

READ MORE

Removing Harmful PFAs From Surfer Shorts to Surgical Drapes

News

Human exposure to unnecessary and potentially harmful chemicals could be greatly reduced if manufacturers add chemicals only when they are truly essential in terms of health, safety and functioning of society.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE